Charles A Annunziato Md - NY Nassau, Garden City 11530

Charles A Annunziato Md entered the industry of Internal Medicine Doctors in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.

To acquire more information, please contact Charles A Annunziato by calling No number given during business hours. You can also write to the business’ Single Location at 1000 Franklin Avenue # 300, Garden City, New York NY 11530. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Charles A Annunziato Md
Representative: Charles A Annunziato
Place of Business: 1000 Franklin Avenue # 300, Garden City, NY 11530
Contact Number: No number given
Type of Service: Internal Medicine Doctors
SIC Number: 8011
NAICS Number: 621111
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1999
Income/Year: $50.000 to $99.999
Laborers: 1 to 4
Share This Company:

Charles A Annunziato Md is a company operating from Nassau, New York providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 1999 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.

With a current employee count of 1 to 4, Charles A Annunziato Md has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Charles A Annunziato at No number given for related queries, or to locate its Single Location using the coordinates 40.729753,-73.635864.

The Single Location can also be found at the street address 1000 Franklin Avenue # 300 in Garden City, New York 11530 and can be engaged online through the company website at , the company Twitter , and Facebook page .